NCT03463187 — Moderate-to-severe Chronic Plaque Psoriasis trial site landscape

Public-registry site landscape for NCT03463187, a Moderate-to-severe Chronic Plaque Psoriasis study sponsored by Jiangsu HengRui Medicine Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03463187 (registry record)
Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Condition(s)	Moderate-to-severe Chronic Plaque Psoriasis
Phase	PHASE1 / PHASE2
Listed sites	13
Site countries	United States, Australia, China

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03463187 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.